Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.48 -0.10 (-3.88%)
As of: Nov 11, 2026 · 3:53 PM EST

Galmed Pharmaceuticals (EOCN) Change in Acquisitions & Divestments (2024 - 2025)

Updated

Galmed Pharmaceuticals' Change in Acquisitions & Divestments came in at -$5.7 million for Q2 2026.

Analysis

Galmed Pharmaceuticals (EOCN) Change in Acquisitions & Divestments (2024 - 2025) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Galmed Pharmaceuticals reported Change in Acquisitions & Divestments of -$8.5 million; for FY2025, it was -$3,000.

  • Going back by year, Change in Acquisitions & Divestments was -$1,000 in FY2024, -$2.2 million in FY2023 and $3.8 million in FY2021 (-84.4%).
  • The Q2 2026 figure represents the lowest quarterly Change in Acquisitions & Divestments since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Galmed Pharmaceuticals 2.06 Mn -38.64 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.90 Mn
Dec 31, 2024 3.33 Mn
Sep 30, 2024 -1.82 Mn
API Access

Galmed Pharmaceuticals Change in Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-acquisitions-and-divestments&ticker=EOCN&period=max&api_key=YOUR_API_KEY